The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies in its fold
Indian Pharmaceutical Alliance (IPA) has announced the names of new office bearers. Nilesh Gupta, Managing Director, Lupin has recently taken over as the President of IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals has been appointed as the Vice President.
The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies in its fold. The current members are Alembic, Lupin, Alkem Laboratories, Mylan Labs, Cadila Healthcare, Micro Labs, Cadila Pharmaceuticals, Natco Pharma, Cipla, Panacea Biotec, Dr Reddy’s Laboratories, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Intas Pharmaceuticals, Unichem Laboratories, Ipca Laboratories, USV, JB Chemicals & Pharmaceuticals and Wockhardt.
Collectively, the IPA Members account for almost 85 per cent of the private sector investment in pharma research and development, contribute 60 per cent of the country’s exports of drugs and pharma, service over 40 per cent of the domestic market, and account for 43 per cent of total sales of essential medicines.